It was widely believed that psychological factors could alter the development and prognosis of various diseases including cancer, as well as injury. It was reported that soldiers injured during a battle in the victorious army could recover from their wounds and survive, whereas the soldiers suffered the similar injury in the defeated army could not recover and died. The fact that the survival period of a husband or wife who has been bereft is extremely short, suggesting that some emotional factors, such as loneliness, anxiety, depression, and frustration caused by the death of his or her beloved may have affected the well-being of the person. The influence of the mind on the immune function was also demonstrated by the ability to use classic Pavlovian conditioning to suppress antibody productionl) and to enhance natural killer cell activity12). More direct evidence for a central and peripheral nervous system origin of immunoregulation comes from observations of both positive and negative effects of electrolytic and chemical lesions of the nervous system on immunologic functions and leukocyte number29).
the damaged tissues. There is a great deal of evidence that immune mechanisms particularly cytotoxic T cells and "natural killer" cells can destroy cancer cells in vitro or in experimental cancer of rodents. Although there is little evidence for a crucial role of the immune system in natural cancer of humans or animals, it is probable that the immune system does play a part in controlling human cancer, and it is relevant to consider the impact of the mind on this system. Stressors such as loud noises, vibration, and handling tend to depress immune reactivity in rodents. Stress can diminish antibody formation, delayed hypersensitivity, and skin allograft rejection in experimental animals. Enhancement by stress has also been recorded and the complexity of its effects is well shown in the study by Monjan and Collector (1974) in which chronic auditory stress diminished lymphocyte functions for the first 3 weeks and enhanced them for the following 3 weeks26). One of the most impressive finding was the demonstration by Bartrop, et al (1977) that the response of peripheral blood lymphocytes was suppressed 8 weeks after bereavement2): this result was independently confirmed by Schleifer et al (1983) . Kiecolt- Glaser et al (1983) have shown that psychiatric inpatients scoring high on a loneliness scale had increased blood corisol levels and relatively low natural-killer cell and lymphocyte stimulation levels23). The most important advance in neuroimmunology is the observation that communication between the neuroendocrine and immune systems is not unidirectional but is bidirectional. Various neuropeptides are indeed produced by leukocytes. The best-studied neuropeptides that are produced by leukocytes are those peptides derived from proopiomelanocortin (POMC). Human peripheral blood lymphocytes and mouse spleen cells were initially observed to express immunoreactive ACTH and endorphins simultaneously following virus infection or interaction with transformed cells or bacterial lipopolysaccharide 4), 32), 33) . Although synthesis of ACTH and endorphins by most lymphocytes are induced by these factors, a subpopulation of mouse splenic macrophages, as well as rat lymphocytes in the tunica propria, produced these peptides in a constitutive fashion 25),10) . These peptides were identified by its antigenicity to a monospecific antibody, retention time on RPHPLC, molecular weight and the biological activity. In addition to POMC drived neuropeptides, the immune system also synthesizes other neuropeptides and hormones, including chorionic gonadotropin, TSH, prolactin, growth hormone, VIP, arginine vasopressin, oxytocin, neurophysisn, and somatostatin. As in pituitary corticotrophs, processing of leukocyte-derived ACTH and 13-endorphin appears to be regulated by corticotropin releasing factor (CRF) or hormone (CRH). As demonstrated on the pituitary, the synthesis of CRH-stimulated POMC related peptides is blocked by dexamethasone. In addition to producing neuropeptides, the immune cells also possess receptors for many neuropeptides and hormones. Mouse spleen mononuclear cells have both high-affinity and low-affinity receptors for ACTH18). Human peripheral blood mononuclear leukocytes are not particularly unlike mouse splenocytes in that they also have both similar high-affinity and low-affinity receptors for ACTH. These findings of the similarities and interactions of the immune and neuroendocrine systems provide a rational for using leukocytes as models of neuroendocrine tissues. It has been shown that ACTH binds specifically to mouse splenocytes and inhibits the production of antibodies and interferon18), 19) . The finding has a clinical implication. In the clinical practice, the inaccessibility of many tissues makes routine investigation for receptor defects impossible. ACTH insensitivity syndrome is an example of this problem. Defects in adrenal ACTH receptors have been postulated because of high circulating ACTH levels and the ability of the adrenal-cortex cells to achieve steroidogenesis through an elevation of cyclic AMP. In the majority of cases, the clinical presentation includes hyperpigmentation, hypoglycemia, and extremely low glucocorticoid levels with normal mineralocorticoid concentrations. Smith et al. (1987) studied leukocyte-ACTH binding in a child known to have isolated glucocorticoid deficiency due to ATCH insensitivity and found that high-affinity ACTH binding did not occur in this patient. The interaction between the immune and neuroendocrine systems is not limited to the regulation of immune cells by neuroendocrine peptide hormones, but also the products of the immune system affect the neuroendocrine function by their direct action on the endocrine organs or through their action on the central neuroendocrine system. We have shown that interleukin 1 (IL-1) suppressed FSH-induced progesterone section and 1251-labeled hCG binding (a measurement of LH receptors) in cultured rat granulosa cells13).
IL-1 produced a dose-dependent inhibition of LH receptors in FSH-stimulated rat granulosa cells, without changing the affinity. A minimum of 12-24 hr of exposure to IL-1 is necessary to significantly inhibit FSH-induced LH receptor formation"). The finding may have clinical implication, because it is known that patients with endometriosis often develop infertility. Endometriosis is known to be associated with infiltration of monocytes in the peritoneum, resulting increased production of IL-1 by these monocytes which may affects the ovarian function.
It has been well established that ACTH release by the pituitary gland is regulated by hypothalamic CRH which is triggered by stress. However, when the stress is extremely severe, such as extensive destruction of tissues, a substance produced by the tissue appears to directly stimulate ACTH release. This substance was named as tissue CRF6). Although three decades have passed since the concept of tissue CRF was presented, tissue CRF has never been isolated or chemically identified. Therefore, we have recently started reexamining various tissues for the presence of a substance with CRF activity which is determined by the release of ACTH by the test material in the rat pituitary cell cultures.
It was recently reported that murine IL-1 stimulated ACTH release from mouse ACTHsecreting pituitary tumor cells (AtT-20), suggesting that IL-1 may be a tissue CRF39).
In our hand, however, neither human IL-la nor IL-10 stimulated the ACTH release from normal pituitary cells in concentrations ranging from 0.01 to 10 nM. IL-113 caused a slight, but significant, increase in ACTH release at a concentration of 100 nM, while IL-la did not, even at the highest dose tested. IL-13 exhibited a synergistic action with synthetic rat CRH in ACTH secretion at 10 and 100 nM of CRH, but the interaction was not striking.
Both of the monokines failed to cause any change in the secretions of growth hormone, prolactin, FSH and LH throughout concentrations ranging from 0.01 to 100 nM. The effects of possible sex-related differences and prolonged preincubation of cultured pituitary cells in serum-free medium prior to assay incubation were also tested, providing no significantly different findings 36). These results suggest that the physiological significance of IL-1 as a tissue CRF is indeed questionable and should be further clarified.
IL-1 administered intravenously (iv), however, consistently elicited a striking ACTH release in conscious unrestrained rats. This ACTH response to IL-1 was completely abolished by preinjection of 0.5 ml rabbit antiserum generated against rat CRH, but not by normal rabbit serum. The IL-1-induced ACTH release did not seem to be caused by a general stress effect of IL-1 because plasma prolactin (PRL) levels, another indicator of a stress response,
were not altered by the injection of IL-137). These results suggest that IL-1 acts centrally in the brain to stimulate the secretion of CRH, thereby eliciting ACTH release, and that a direct action of IL-1 on the pituitary gland is unlikely. In order to confirm that the primary site of action of IL-i/3 in stimulation of ACTH release is the brain, the ACTH responses to IL-10 administered iv and intracerebroventricularly (icy) in conscious rats were compared. A dose as small as 3 ng of IL-113 injected icy induced a significant rise in plasma ACTH levels, whereas 100 ng/100g was needed for a significant response when injected iv. ICV injection of 0.3 ng IL-la tended to increase plasma ACTH levels, but not significantly. IV injection of 1000 ng/100 g IL-1a induced a maximal response with a pronounced elevation of plasma ACTH levels at 10 and 30 min after injection, but plasma ACTH levels fell at 60 min post injection. On the other hand, icy injection of 30 ng IL-1 g raised plasma ACTH levels at 10 min, reaching peak values between 30 and 60 min post injection, and plasma ACTH levels remained elevated for 2-3 h after injection. As demonstrated for pyrogen-induced febrile reaction, pretreatment with indomethacin completely prevented the ACTH response induced by either iv or icy injection of IL-i13. Administration of indomethacin did not alter the elevation of plasma ACTH levels induced by immobilization stress, however. On the other hand, vagotomy did not alter the ACTH response to iv administered IL-10. Neither iv or icy injection of IL-10 in a dose which induced a maximal ACTH response altered plasma PRL levels. These findings strongly suggest that the brain is the primary site of action of HAp, and that IL-10 transmits the message of the immune system to the brain and, possibly, CRH neurons. It is also suggested that prostaglandins may be involved in this central action of IL-1021).
The next question is how blood-borne IL-1 with a mw of 17,500 reaches the brain tissue crossing the blood-brain-barrier (BBB). It has been suggested that IL-1 induces fever through its central action and that the primary site in the brain for the febrile reaction to blood-borne pyrogen is the preoptic area (POA) 8). Other reports indicated that placement of lesions in the anteroventral area of the third ventricle and the organum vasculosum of the lamina terminalis (OVLT) altered febrile response to systemic injection of pyrogen34). It was suggested that the circulating IL-1 or pyrogen may reach the brain tissues through a region where the BBB is absent, such as the circumventricular organs. Studies of the ultrastructures of the OVLT and subfornical organ (SFO) of the circumventricular organs suggested that they have both sensory and neurosecretory functions38). The OVLT and SFO were also reported to be the most sensitive areas for the "drinking response" induced by systemic angiotensin Electrical stimulation of neurons in the POA which is adjacent to both OVLT and SFO has been demonstrated to increase firing rates of neurons in the paraventricular nucleus (PVN) and plasma corticosterone levels in rats 3°). Bearing these reports in mind, we examined the effects of iv injection of IL-1 on ACTH release in conscious rats bearing lesion in the OVLT, SFO, or POA in order to determine whether these areas might be involved or were essential to the mechanism by which blood-borne IL-113 triggers ACTH release (Katsuura et al, in press). In addition, the purported involvement of PGs in IL-113-induced ACTH response was also investigated. The lesion in the specific area of the rat brain was made either by radiofrequency current (RL) or microinjection (1/..d) of kainic acid (KL), a neurotoxin, by the aid of a stereotaxic instrument. Microinjection of the material in the conscious rats was made through the guide cannula implanted on the skull.
The effect of RL and KL of the OVLT on ACTH response to iv injection of IL-113
(1 mg/100 g BW) was examined 1 week post-operatively. IL-113 iv in sham-operated rats induced a significant elevation of plasma ACTH levels at 10 and 30 min postinjection, with peak levels occurring at 10 min to a similar extent as the ACTH response in the intact rats in our previous experiments. Insertion of the electrode for RL into the OVLT without passing a current (sham operation) did not alter basal ACTH levels or the ACTH response to IL-113 one week after the operation. On the other hand, the ACTH response to IL-113 was markedly enhanced in rats with RL of the OVLT, as compared with that of shamoperated animals. ACTH levels in OVLT-lesioned rats were 1.8-fold higher than in shamoperated rats 10 min postinjection of IL-1j3. ACTH levels at 60 min postinjection were still higher than the corresponding values. Similarly, an enhanced ACTH response to IL-113 was demonstrated in rats with OVLT lesion induced by 0.3/1g kainic acid. ACTH levels 30 and 60 min after IL-113 injection were 2.0 and 3.1 times higher than corresponding values in the sham-operated control rats which received 1 /..il 0.9% saline. A similar result was obtained in the rats with OVLT lesion induced by 3/1g of kainic acid. ACTH levels 10, 30 and 60 min after IL-1/3 injection iv were 1.9, 2.3 and 5.8 times higher than corresponding values in the sham-operated rats. At 120 min after IL-113 injection, ACTH levels returned to basal levels.
The effect of OVLT lesion on ACTH response to iv injection of IL413 was also examined 3 weeks post-operatively. The ACTH response in rats with RL and sham-operated control rats was similar. However, in rats with KL the ACTH response remained augmented. The effect of RL of the SFO on ACTH response to IL-10 iv was also examined 1 week postoperatively. RL of the SFO altered neither basal ACTH levels nor ACTH response to IL-113 iv significantly, suggesting that SFO is not the essential area in the pathway through which IL-1 triggers ACTH release.
As mentioned before, iv administration of indomethacin (Idm) (1 mg/100g BW) completely blocked ACTH response to IL-113 iv in rats. The findings described above suggests that the OVLT may be a site where transduction of blood-borne immune signals carried by IL-1j3 into neuronal signals may take place; and that non-neuronal elements, not destroyed by RL or KL, in and near the OVLT, such as astrocytes, are involved in ACTH secretion.
Studies by others have shown that astrocytes were proliferated by RL or KL9) and it has ACTH response to IL-113 was also examined in rats bearing bilateral RL or KL in POA. Control rats were either sham-operated or injected with 1/11 0.9% saline in the POA one week prior to the experiments with IL-10 iv which resulted in significant elevation of plasma ACTH levels at 10 and 30 min postinjection in these control rats to the same extent as demonstrated in intact animals. On the other hand, in animals with RL in POA, plasma ACTH levels at 10 and 30 min postinjection were reduced to 45 and 60% of levels of shamoperated control rats, respectively. ACTH levels at 10 and 30 min after IL-1f3 injection in the animals with KL in POA were also reduced to 70 and 65% of the corresponding values of rats which received microinjection of saline in the POA 7 days before the experiment.
Neither RL or KL of POA altered basal plasma ACTH levels. It is possible that POA lesion may suppress ACTH release by affecting a common pathway for CRH-ACTH stimulation.
Therefore, an experiment was conducted to examine whether RL in the POA would also suppress ACTH release induced by immobilization stress. The increase in plasma ACTH levels resulting from immobilization stress was not diminished by RL in the POA, suggesting the suppression of IL-10-induced ACTH response by POA lesion is specific.
In other experiment, PGE antagonist (SC-19220) was microinjected into the POA bilaterally (1 p1/1 p1 saline) in each side 5 min before injection of IL-1j3 iv. This treatment completely blocked the ACTH response to IL-113 iv. Microinjection of 1 pl 0.9% saline into the POA did not alter basal ACTH levels or ACTH response to IL-113 iv. On the other hand, microinjection of PGE2 (1 pg/1 p1 saline) into the POA resulted in considerable elevation of plasma ACTH levels over a 2 h period after injection. PGE1 (1 pg/1 p1 saline) also induced significant increase in plasma ACTH levels at 10 min after microinjection, but to a lesser extent. Microinjection of PGD2 (1 gg/1 //1 saline) into the POA did not increase plasma ACTH levels. Plasma ACTH levels were also increased at 10, 30 and 60 min after microinjection of PGE2 (2/.2g/1121 saline) into the OVLT. However, the ACTH response appeared to be smaller than that resulting from microinjection of PGE2 into the POA. The result suggest that the POA is the primary site of action of PGE2 with regard to the stimulation of ACTH release.
It is interesting that RL and KL of the OVLT resulted in a considerably enhanced ACTH response to IL-1(3 iv one week post-operatively. The magnitude of the response, however, returned to a normal level 3 weeks after placement of RL but still remained enhanced after KL. The pattern observed after RL appears to be similar to the change in febrile response induced by systemic injection of pyrogen that was enhanced 6 days after placement of electrolytic lesion in OVLT in rabbits and rats, and returned to the control level 19 days after the operation34). Since physical damage of the brain tissues temporarily increased permeability of the local blood vessels at the site of injury (Klatzo et al, 1958) , it is possible that RL also increases permeability of the local blood vessels in the lesioned area. This state of increased vascular permeability persists for 19 days and then returns to normal (Klatzo et al, 1985) . It is, therefore, possible that blood-borne IL-1j3 has better access to the brain tissue through the lesioned OVLT 1 week postoperatively than at 3 weeks postoperatively when vascular permeability has returned to normal. Therefore, the enhanced ACTH response to IL-113 iv 1 week after RL in the OVLT might be partly explained by the temporal increase in the vascular permeability resulting from RL. This view, however, is not likely to explain the mechanism of an enhanced ACTH response to IL-113 in rats bearing KL of the OVLT which does not damage the vascular structure. An increased ACTH response to IL-113 iv perisisted 3 weeks after microinjection of kainic acid in the OVLT. Morphological and biochemical studies showed that one of the effects of kainic acid in the brain is increased proliferation of astrocytes for 27 days (Nicklas et al, 1979) , which is comparable with our result that ACTH response to IL-113 in rats with KL of the OVLT was enhanced for 3 weeks. Mechanical injury of brain tissue, including RL, is also known to stimulate proliferation of astrocytes which produce nerve growth factor for repair of the damaged neuronal tissue. Neuronal cell structures, both cell bodies and fibers, in the OVLT may not be required for IL-1-induced ACTH response, because although RL destroyed these neuronal structures, the ACTH response remained augmented one week after placement of lesion. Therefore, these findings support our postulation that IL-10 acts on non-neuronal components, most likely astrocytes in the OVLT. Astrocytes proliferated by lesion or kainic acid may release a larger amount of a mediator which induced the enhancement of ACTH response in response to IL-1j3. Lesion induced by either RL or KL in the POA resulted in an entirely opposite effect on the IL-10-induced ACTH response. In this area, lesion suppressed the response. Lesion in the SFO had no effect on the response. Decreased response following POA lesion suggests that the neuronal elements essential for the ACTH response to IL-113 were interfered with. In other words, the neuronal structures, especially kainic acid-sensitive cell bodies, in the POA may play an important role in the transmission of the immune signal to CRH neurons.
Our recent study demonstrated that IL-10 stimulated the release of PGE2 from rat astrocyte cultures, but not from neuron cultures22). The present experiment showed that Idm microinjected into the OVLT suppressed IL-1j3-induced ACTH release. This finding supports the view that PGs synthesized and released from astrocytes in the OVLT, following entry of blood-borne IL-113 into these tissues, may represent a transduced form for the signal carried by IL-113 to which the neurons respond. Since the POA is located in close proximity to the OVLT, it is possible that PGs diffuse to the POA from the OVLT. The wide spaces, not found elsewhere in the brain, which surround the capillaries in the OVLT and other circumventricular organs may be specialized "pools" for the mixing and rapid interstitial distribution of chemical substances such as PGs. While ion concentrations in the brain cell microenvironment of interstitial fluid (ISF) may be viewed as stable over long periods of time, neuronal function is associated with short-term variations in ISF composition27). There are also changes in the concentrations of other chemical components, including classical transmitters, peptides, PGs etc.27). Evidence is now accumulating that these dynamic variations are not "noise", but that they represent "meaningful signals" to neighboring neurons and glial cells27). According to this concept, signals may be carried to neighboring cells, or even over longer distances, by neuroactive substances circulating within the isolated milieu of the brain behind the blood-brain barrier.
Neurons in the POA may play an important role in transmitting the immune signal to CRH neurons in PVN. It is possible that thse neurons in the POA respond directly to PGs, or indirectly via classical neurotransmitter interneurons. The present study showed that PGE2 microinjected into the POA induced a greater response than injection into the OVLT.
Complete abolishment of the ACTH response to IL-1j3 iv after microinjection of PGE2 antagonist into the POA may substantiate that the target cells for PGE2 involved in the IL-1-induced ACTH response mechanism are present in the POA.
Moreover, IL-1 appears to be synthesized in neurons and astrocytes 5)' 11). IL-1 may also be considered as a growth factor which is involved in repair of damaged neuronal tissues (Neito-Sampedra, Berman, 1988). Whether endogenous IL-1 in the brain is also involved in the ACTH response to blood-borne IL-1 is unclear. Although experimental manipulation such as insertion of an electrode or cannula into the OVLT or POA might stimulate release of endogenous IL-1, the failure to increase plasma ACTH levels in shamoperated animals indicates that involvement of endogenous IL-1 in the acute ACTH response to IL-1 iv is negligible.
It is likely that the neurons in the POA activated by PGE2 transmit the signal to the CRH neurons in the PVN. A recent electrophysiological study by others demonstrated that microapplication of arachidonate in the POA altered the firing rate of some neurons in that area 16) , and that stimulation of the POA by high frequency current resulted in an increased firing of neurons in the PVN and increased plasma corticosterone levels3O). Moreover, histochemical studies using transport of horseradish peroxidase in the neuronal fibers demonstrated a direct connection between the neurons in the POA and those in the PVN7).
Based on the present result as well as other studies, we propose the following hypothesis regarding the central mechanism of ACTH release induced by blood-borne IL-10. Blood-borne IL-1(3 penetrates the fenestrated endothelium of the OVLT and enters into the perivascular region where it activates the astrocytes abundantly present in this area.
These astrocytes then release PGE2 into interstitial spaces and PGE2 diffuses, or is transported within the isolated milieu behind the BBB toward its target neurons in the POA. PGE2 binds its specific neuronal receptors and then activates the neuronal activity which is 
